Literature DB >> 342425

Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease.

O Eremin, J Ashby, J P Stephens.   

Abstract

Natural cytotoxicity against CLA-4 and D6 target cells was determined in the peripheral blood of healthy donors and women with mammary carcinoma (localized to the breast and axilla), and in human normal and regional tumour lymph nodes. The NK cell activity in the blood of women with clinically localized mammary carcinoma showed a wide range of reactivities but was similar to the pattern detected in healthy controls. The NK cell activity in human normal lymph nodes also showed a wide range and was the same irrespective of the anatomical site of origin of the lymph node. Lymph nodes draining a variety of solid tumours had a similar spectrum of NK cell activity, there being no obvious correlation between the level of NK cell activity and such parameters as size and histological type of tumour, hyperplasia or metastatic spread in the regional node. Trypsin treatment of lymphocyte suspensions from the various lymphoid compartments suggested that the cell responsible for natural cytotoxicity in blood was probably different from the NK cell in tonsil and lymph nodes.

Entities:  

Mesh:

Year:  1978        PMID: 342425     DOI: 10.1002/ijc.2910210108

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Natural killer cells: artifact to reality: an odyssey in biology.

Authors:  R K Oldham
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Variation in natural killer activity in peripheral blood during the menstrual cycle.

Authors:  A N Sulke; D B Jones; P J Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

3.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

4.  Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinoma.

Authors:  I Kimber; M Moore; A Howell; M J Wilkinson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer.

Authors:  E Robinson; D Rubin; T Mekori; R Segal; S Pollack
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

6.  The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.

Authors:  P R Gibson; D P Jewell
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

7.  Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.

Authors:  E Yanagawa; A Uchida; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Medullasin enhances human natural killer cell activity.

Authors:  Y Aoki; M Sumiya; K Oshimi
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  Effect of simple sugars on natural killing: evidence against the involvement of a lectin like mechanism in target recognition.

Authors:  B M Vose; M Harding; W White; M Moore; J Gallagher
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

10.  Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer.

Authors:  A Fulton; G Heppner; L Roi; L Howard; J Russo; M Brennan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.